NBC News reported that the U.S. Department of Health Human Services purchased almost the entire existing supply of remdesivir, a medication patented by Gilead Sciences which has shown promising results when applied to a limited group of very sick CV-19 patients.
According to the report, the U.S. ordered the entire stock of the possible virus cure for the coming month as well as 90% over the remainder of the summer and September.